Vos Ellen O'Connor 4

What Happened Ellen O'Connor, a director of Modular Medical, Inc. (MODD), received a grant/award on March 31, 2026 consisting of a derivative security covering 250 shares (reported as an option). The filing lists no exercise price or total dollar value. The award was granted under the issuer's Outside Director Compensation Plan and, per the filing, the option was fully vested and immediately exercisable on the grant date. This was a compensation award (not an open‑market purchase or sale).

Key Details

• Transaction date: 2026-03-31 (Form 4 filed 2026-04-08).
• Transaction code: A (award/grant/other acquisition); quantity: 250 derivative shares (option covering 250 shares).
• Price/value: Not disclosed in the filing (exercise price listed as N/A).
• Shares owned after the transaction: Not specified in the filing (column 9/beneficial ownership of the derivative class not reported).
• Footnotes:
  • F1: Option granted under the issuer's Outside Director Compensation Plan; fully vested and exercisable on grant date.
  • F2: Column 9 reports only total beneficial ownership for the reported "class" of derivative; options with different exercise prices/vesting are not treated as the same class.
• Filing timeliness: Form filed April 8, 2026; the filing itself does not include a late‑filing indicator in the materials provided here.

Context This was a director compensation award (an option grant) rather than an open‑market purchase or sale. Because the option was fully vested and immediately exercisable, O'Connor could exercise it right away, but the filing does not state whether she has exercised or sold any shares. Director option grants are common as compensation and should be interpreted as such; they do not by themselves indicate a buy/sell decision in the market.